The results of this interesting study showed that more than 80% of PanIN and IPMN lesions do not have common somatic copy number gene alterations; in contrast, about 95% of PanINs and IPMNs harbor mutations in KRAS [25]. This evidence concerns the gene KRAS and pancreatic intraductal papillary-mucinous neoplasm.